World News: 21:01 GMT Wednesday 11th September 2019. [CareDx, Inc. via Globe Newswire via SPi World News]
BRISBANE, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that, as an inducement material to entering into employment with CareDx, on September 11, 2019, 53 new employees were awarded grants of stock options and restricted stock units (RSUs). The stock options and RSUs were granted pursuant to the Company’s 2019 Inducement Equity Incentive Plan, which was approved by the Compensation Committee of the Board of Directors in August 2019 under Nasdaq Listing Rule 5635(c)(4).
The RSUs vest over four years with 25% of the RSUs vesting on the first anniversary of the applicable vesting commencement date, and the balance vesting annually thereafter in three equal installments, subject to continued service through each applicable vesting date. The stock options vest over four years with 25% of the stock options vesting on the first anniversary of the applicable vesting commencement date, and the balance vesting on an equal monthly basis over the following 36 months, subject to continued service through each applicable vesting date.
CareDx is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4).
For more information, please visit: www.CareDx.com.
CareDx, Inc.Sasha KingChief Commercial Officer415email@example.com
Investor RelationsDavid ClairWestwicke Partners646firstname.lastname@example.org
Globe Newswire: 21:01 GMT Wednesday 11th September 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.